Beck A T, Ward C H, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry4: 53–63
2.
Curran H V, Travill R A (1997) Mood and cognitive effects of 3, 4-methylenedioxymethamphetamine (MDMA ‘ecstacy’): week-end ‘high’ followed by mid-weeek low. Addiction92: 821–831
3.
Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delsignore R (1998) Serotonergic function after (±)3,4-methylene-dioxymethamphetamine (‘ecstasy’) in humans. Int Clin Psychopharmacol13: 1–9
4.
Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, Marzocchi G F, Delsignore R, Brambilla F (2000) Long-lasting effects of (±)3,4-methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans. Biol Psychiatry47: 127–136
5.
MacInnes N, Handley S L, Harding G F A (2001) Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depression. J Psychopharmacol15: 181–186
6.
Tse W S, Bond A J (2001) Serotonergic involvement in the psychosocial dimension of personality. J Psychopharmacol15: 195–198
7.
Verkes R J, Gijsman H J, Pieters M S M, Schoemaker R C, de Visser S, Kuijpers M, et al. (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology153: 196–202
